BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raggi C, Taddei ML, Rae C, Braconi C, Marra F. Metabolic Reprogramming in Cholangiocarcinoma. J Hepatol 2022:S0168-8278(22)00314-2. [PMID: 35594992 DOI: 10.1016/j.jhep.2022.04.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiu S, Wang Y, Rao H, Que Q, Wu Y, Zhu R, Feng X, Chi J, Lai W, Sun Y, Xiao Q, Shi H, Xiang Y. Tumor microenvironment-associated lactate metabolism regulates the prognosis and precise checkpoint immunotherapy outcomes of patients with lung adenocarcinoma. Eur J Med Res 2022;27:256. [DOI: 10.1186/s40001-022-00895-6] [Reference Citation Analysis]
2 Luo Y, Deng F, Zhang Y, Xiao Y. Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer. Front Cell Dev Biol 2022;10:1014565. [DOI: 10.3389/fcell.2022.1014565] [Reference Citation Analysis]
3 Wu W, Pu Y, Zhou B, Shen Y, Gao S, Zhou M, Shi J. Photoactivatable Immunostimulatory Nanomedicine for Immunometabolic Cancer Therapy. J Am Chem Soc 2022. [PMID: 36215038 DOI: 10.1021/jacs.2c07872] [Reference Citation Analysis]
4 Wu H, Wang M, Zhu J, Li Z, Wang W, Gu L, Shen F, Yang T. Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine. Pharmaceutics 2022;14:1760. [DOI: 10.3390/pharmaceutics14091760] [Reference Citation Analysis]